STAAR Surgical (STAA) vs Warby Parker (WRBY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Warby Parker (WRBY) has outperformed STAAR Surgical (STAA) over the past year, gaining 2.4% versus a loss of 16.3%. Over five years, WRBY leads with a -53.8% price change compared with -80.5% for STAA. Warby Parker is the larger company by market cap ($2.99 billion vs $1.11 billion), about 2.7 times the size.
On valuation, STAAR Surgical trades at a lower forward P/E (19.9x vs 39.4x for Warby Parker).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | STAA | WRBY |
|---|---|---|
| Share price | $22.09 | $24.21 |
| Market cap | $1.11B | $2.99B |
| 1-day change | -1.21% | -4.35% |
| YTD return | -3.16% | +16.15% |
| 1-year return | -16.32% | +2.43% |
| 5-year return | -80.54% | -53.77% |
| P/E ratio (TTM) | 276.13 | 403.50 |
| Forward P/E | 19.88 | 39.38 |
| EPS (TTM) | $0.08 | $0.06 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $871.90M |
| Revenue growth (YoY) | — | +13.04% |
| Net income (latest FY) | — | $1.64M |
| Gross margin | — | 53.97% |
| Operating margin | — | -0.61% |
| Net margin | — | 0.19% |
| 52-week high | $35.87 | $31.00 |
| 52-week low | $15.59 | $14.96 |
| Distance from 52-week high | -38.42% | -21.90% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +26.75% | +25.82% |
| Average volume | 998.64K | 2.85M |
| Shares outstanding | 50.14M | 108.24M |
| Employees | 921 | 2,275 |
| Sector | Health Care | Health Care |
| Industry | Ophthalmic Goods | Ophthalmic Goods |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Warby Parker is about 2.7 times larger than STAAR Surgical by market value ($2.99B vs $1.11B).
- WRBY has outperformed STAA by 18.7 percentage points over the past year.
- Warby Parker trades at a higher earnings multiple (403.5x vs 276.1x trailing P/E).
About STAAR Surgical
STAA stock →STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells phakic implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company offers implantable collamer lens product family (ICLs) comprising EVO ICL, EVO+ ICL, EVO Visian ICL, and EVO Viva ICL for use in refractive surgery for the treatment of visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia.
Health Care · Ophthalmic Goods · 921 employees
About Warby Parker
WRBY stock →Warby Parker Inc. sells eyewear products through its retail and e-commerce platform in the United States and Canada.
Health Care · Ophthalmic Goods · 2,275 employees
STAA vs WRBY FAQ
Which is bigger, STAAR Surgical or Warby Parker?
Warby Parker (WRBY) is larger, with a market capitalization of $2.99B compared with $1.11B for STAAR Surgical (STAA).
Which stock has performed better over the past year, STAA or WRBY?
WRBY returned +2.43% over the past 12 months, compared with -16.32% for STAA (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, STAA or WRBY?
STAA has the lower trailing P/E at 276.1, versus 403.5 for WRBY. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are STAAR Surgical and Warby Parker in the same industry?
Yes. Both are classified in the Ophthalmic Goods industry within the Health Care sector.